Dr. Lisa Ramaut from the Department of Plastic, Reconstructive, and Aesthetic Surgery at the Brussels University Hospital (UZ ...

Nicknamed the “man with the golden arm,” James Harrison donated his blood over 1,100 times over the course of six decades.

Takeda paid Protagonist $300 million one year ago to license rights to rusfertide, which the companies are developing to ...

Among phlebotomy-dependent patients with polycythemia vera, the addition of rusfertide to standard-of-care treatment resulted ...

An experimental medicine from Protagonist Therapeutics stabilized red blood cells and improved symptoms in patients with a ...

Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a ...

Although altitude training had been used for many years, the last few years it has become incredibly popular with endurance ...

James Harrison, a prolific Australian blood donor famed for having saved the lives of more than two million babies, has died at age 88. Harrison, whose plasma contained a “rare and precious antibody” ...

James Harrison, who donated blood more than 1,000 times and became famous for saving the lives of more than two million ...

The TRAVERSE trial, a large-scale clinical study with over 5,000 patients, published in 2023, concluded that TRT does not increase the risk of adverse cardiovascular outcomes in men with hypogonadism.

Each type can also be either Rh-positive (+) or Rh-negative (-), depending on whether they carry the Rh factor protein. Knowing your blood type is critical in emergencies, as receiving the wrong blood ...